. Author manuscript; available in PMC: 2016 Mar 1.

Published in final edited form as: Transplantation. 2015 Mar;99(3):602–608. doi: 10.1097/TP.0000000000000354

TABLE 2.

Posttransplant Recipient CMV and EBV Replication Stratified by Pretransplant Donor-Recipient Antibody Status for the Corresponding Virus

Donor Recipient Serology	KIDNEY (n=83)				LIVER (N=15)
Donor Recipient Serology	EBV viral replication in urine/oral wash post-tx (p 0.8)	EBV viremia post-tx (p 0.09)	CMV viral replication in urine/oral wash post-tx (p 0.2)	CMV viremia post-tx (p 0.02)	EBV viral replication in urine/oral wash post-tx (p 0.8)	EBV viremia post-tx (p 0.8)	CMV viral replication in urine/oral wash post-tx	CMV viremia post-tx
D+R−	5/19 (32%)	8/19 (42%)	1/17 (12%)	6/17 (35%)	0	0	0	0
D+R+	16/61 (33%)	10/61 (16%)	1/23 (9%)	8/23 (35%)	2/13 (15%)	2/13 (15%)	0/3 (0%)	0/3 (0%)
D−R+	0/1 (0%)	0/1 (0%)	2/13 (8%)	3/13 (23%)	0/1 (0%)	0/1 (0%)	0/4 (0%)	0/4 (20%)
D−R−	0/2 (0%)	0/2 (0%)	0/30 (0%)	1/30 (3%)	0/1 (0%)	0/1 (0%)	0/8 (0%)	0/8 (25%)